Literature DB >> 15680722

Outflow tract tachycardia with R/S transition in lead V3: six different anatomic approaches for successful ablation.

Hildegard Tanner1, Gerhard Hindricks, Petra Schirdewahn, Richard Kobza, Anja Dorszewski, Christopher Piorkowski, Jin-Hong Gerds-Li, Hans Kottkamp.   

Abstract

OBJECTIVES: The aim of this study was to analyze different anatomic mapping approaches for successful ablation of outflow tract tachycardia with R/S transition in lead V(3).
BACKGROUND: Idiopathic ventricular tachycardia can originate from different areas in the outflow tract, including the right and left ventricular endocardium, the epicardium, the pulmonary artery, and the aortic sinus of Valsalva. Although electrocardiographic criteria may be helpful in predicting the area of origin, sometimes the focus is complex to determine, especially when QRS transition in precordial leads is in V(3).
METHODS: We analyzed surface electrocardiograms of 33 successfully ablated patients with outflow tract tachycardia: 20 from the right ventricular outflow tract (RVOT) and 13 from different sites. The R/S transition was determined, and the different anatomic approaches needed for successful catheter ablation were studied.
RESULTS: Overall, R/S transition in lead V(3) was present in 19 (58%) of all patients. In these patients, mapping was started and successfully completed in the RVOT in 11 of 19 (58%) patients. The remaining eight patients with R/S transition in lead V(3) needed five additional anatomic accesses for successful ablation: from the left ventricular outflow tract (n = 3), aortic sinus of Valsalva (n = 2), coronary sinus (n = 1), the epicardium via pericardial puncture (n = 1), and the trunk of the pulmonary artery (n = 1), respectively.
CONCLUSIONS: A R/S transition in lead V(3) is common. In patients with outflow tract tachycardia with R/S transition in lead V(3), a stepwise endocardial and epicardial mapping through up to six anatomic approaches can lead to successful radiofrequency catheter ablation.

Entities:  

Mesh:

Year:  2005        PMID: 15680722     DOI: 10.1016/j.jacc.2004.10.037

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

1.  Coupling interval variability differentiates ventricular ectopic complexes arising in the aortic sinus of valsalva and great cardiac vein from other sources: mechanistic and arrhythmic risk implications.

Authors:  Jason S Bradfield; Mohamed Homsi; Kalyanam Shivkumar; John M Miller
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

2.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

3.  Linear segmental isolation of the left coronary cusp to eliminate ventricular arrhythmia originating in close proximity to left main coronary artery.

Authors:  Mayurkumar D Bhakta; Dan Sorajja; Luis R P Scott; Komandoor Srivathsan
Journal:  J Interv Card Electrophysiol       Date:  2011-06-04       Impact factor: 1.900

Review 4.  Ablation of idiopathic ventricular tachycardia.

Authors:  Doreen Schreiber; Hans Kottkamp
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

Review 5.  Conventional mapping and ablation of focal ventricular tachycardias in the healthy heart.

Authors:  Sonia Busch; Johannes Brachmann; Ahmed Saleh; Mathias Forkmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-05-08

6.  The V1-V3 transition index as a novel electrocardiographic criterion for differentiating left from right ventricular outflow tract ventricular arrhythmias.

Authors:  Chengye Di; Zheng Wan; Gary Tse; Konstantinos P Letsas; Tong Liu; Michael Efremidis; Jianming Li; Wenhua Lin
Journal:  J Interv Card Electrophysiol       Date:  2019-09-02       Impact factor: 1.900

7.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

8.  Catheter ablation of idiopathic ventricular tachycardia.

Authors:  Marmar Vaseghi; Kalyanam Shivkumar
Journal:  Circ Arrhythm Electrophysiol       Date:  2010-06

9.  Rapid mapping and differentiation in ventricular outflow tract arrhythmia using non-contact mapping.

Authors:  Kazuo Miyazawa; Marehiko Ueda; Yusuke Kondo; Tomohiko Hayashi; Miyo Nakano; Masayuki Ishimura; Masahiro Nakano; Yoshio Kobayashi
Journal:  J Interv Card Electrophysiol       Date:  2017-04-06       Impact factor: 1.900

Review 10.  Which Is The Appropriate Arrhythmia Burden To Offer RF Ablation For RVOT Tachycardias?

Authors:  Andreas Rillig; Tina Lin; Feifan Ouyang; Karl-Heinz Kuck; Roland Richard Tilz
Journal:  J Atr Fibrillation       Date:  2014-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.